in the global race for corona virus vaccines by antec pfizer was 1st out of the gate a proud achievement for buy on tac the german company that went from start up to pharma superstar now in the debate over waiving patents on proving 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and jab at the biden administration german health minister again sean had this to say the least if the real product it isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extending their

in the global race for corona virus vaccines by antec pfizer was 1st out of the gate a proud a chief meant for by on tech the german company that went from start up to pharma superstar now in the debate over waiving patents on 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and jab at the biden administration german health minister again spun had this to say the least if the real problem it isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed an export folks who get. the us is just one of the wealthy nations accused of vaccine hoarding extending their

food and drug administration has given the pfizer buy antec coated 1000 vaccine emergency use the authorization for children between the ages of 12 and 15 of the 2 dose vaccine has of course been approved for the those over the age of 16 since december of last year and has been key in the nation's vaccination drive it now faces approval by the centers for disease control and prevention the vaccine advisory committee which is scheduled to meet wednesday if approved the drug could be rolled out to the age group before the end of the week last month pfizer's senior vice president of vaccine clinical research and development dr william gruber he spoke about the company's data regarding the use of the vaccine in the younger demographic. obviously we are very eager for this vaccine to make it into the arms of 12 year old children as soon as possible for their benefit. or her protection we know the immune response that we got the older adults we know the vaccine implications so we get the same immune response of 12 to 18 year olds then we should expect the same level of effort as we did even better th

in the global race for corona virus vaccines by antec pfizer was 1st out of the gate a proud a chief meant for by on tac the german company that went from start up to pharma superstar now in the debate over waiving patents on covert 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and in a jab at the biden administration german health minister again spun had this to say the least if the real problem it isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extend

food and drug administration has given the pfizer buy antec covert 1000 vaccine emergency use the authorization for children between the ages of 12 and 15 of the 2 dose vaccine has of course been approved for the those over the age of 16 since december of last year and has been key in the nation's vaccination drive it now faces approval by the centers for disease control and prevention the vaccine advisory committee which is scheduled to meet wednesday if approved the drug could be rolled out to the age group before the end of the week last month pfizer's senior vice president of vaccine clinical research and development dr william gruber he spoke about the company's data regarding the use of the back seat in the younger demographic. obviously we are very eager for distraction to make it into the arms of a 12 year old children as soon as possible for their benefit and. heard protection we know the immune response that we got in older adults we know the vaccine implications seem immune response of 12 to 15 year olds then we should expect the same level of effort as we did even better than we act

in the global race for corona virus vaccines by antec finds her was 1st out of the gate a proud achievement for buy on tac the german company that went from start up to pharma superstar now in the debate over waiving patents unproven 1916 the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and in a jab at the biden administration german health minister again sean had this to say the least if the real problem isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed and was also an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extending t

in the global race for corona virus vaccines by antec pfizer was 1st out of the gate a proud a chief meant for by on tac the german company that went from start up to pharma superstar now in the debate over waiving patents on proving 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and in a jab at the biden administration german health minister again spun had this to say the least if the real problem isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed it was an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding e

in the global race for corona virus vaccines by antec pfizer was 1st out of the gate a proud achievement for buy on tac the german company that went from start up to pharma superstar now in the debate over waiving patents on covert 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine pretty.